DSC Equity Fund – Healthcare A|A

Reference Data

ISIN AT0000A1FNT0
Valor Number 28871817
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A|A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 197.34 CHF 03.06.2025
Previous Price * 198.22 CHF 02.06.2025
52 Week High * 246.77 CHF 03.09.2024
52 Week Low * 193.89 CHF 22.04.2025
NAV * 197.34 CHF 03.06.2025
Issue Price * 203.27 CHF 03.06.2025
Redemption Price * 197.34 CHF 03.06.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 41,387,253
Unit/Share Assets *** 29,840,336
Trading Information SIX

Performance

YTD Performance -11.86% 30.12.2024
03.06.2025
1 month -4.31% 05.05.2025
03.06.2025
3 months -16.84% 03.03.2025
03.06.2025
6 months -15.14% 03.12.2024
03.06.2025
1 year -16.36% 03.06.2024
03.06.2025
2 years -10.69% 05.06.2023
03.06.2025
3 years -15.94% 03.06.2022
03.06.2025
5 years -9.30% 03.06.2020
03.06.2025

Tax Data

Equity Participation Rate in % 97.27
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 8.07%
Johnson & Johnson 6.91%
UnitedHealth Group Inc 5.23%
Abbott Laboratories 5.02%
AbbVie Inc 4.40%
Merck & Co Inc 3.95%
Sanofi SA 3.53%
AstraZeneca PLC 3.41%
Intuitive Surgical Inc 3.09%
Amgen Inc 2.82%
Last data update 30.04.2025

Cost / Risk

TER 1.53%
TER date 30.04.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.52%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)